LOAMU
BMY.RT

Lombard Odier Asset Management (USA)’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-85,000
Closed -$59K – 439
2020
Q4 		$59K Buy
+85,000
New +$181K ﹤0.01% 241
2020
Q3 		– Sell
-297,183
Closed -$1.06M – 330
2020
Q2 		$1.06M Buy
297,183
+60,000
+25% +$216K 0.07% 174
2020
Q1 		$901K Sell
237,183
-26,354
-10% -$86.8K 0.09% 146
2019
Q4 		$793K Buy
+263,537
New +$685K 0.07% 178

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s BMY.RT Position: Q1 2021 in Review

Lombard Odier Asset Management (USA) sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 85,000 shares — an estimated $59K sold.

Lombard Odier Asset Management (USA) first reported a position in BMY.RT in Q4 2019 and held it in 4 quarters. The position peaked at $1.06M in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Lombard Odier Asset Management (USA) reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 85,000 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $59K.
  • Lombard Odier Asset Management (USA) first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 4 quarters.
  • Lombard Odier Asset Management (USA)'s Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1.06M in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2021, filed 17 May 2021.